These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9574466)

  • 81. Simplified determination of the lipid components of blood serum.
    CONNERTY HV; BRIGGS AR; EATON EH
    Clin Chem; 1961 Feb; 7():37-53. PubMed ID: 13695063
    [No Abstract]   [Full Text] [Related]  

  • 82. Serum lipids in normal adults; a follow up study.
    LINDHOLM H
    Acta Med Scand; 1957 Apr; 157(3):205-8. PubMed ID: 13424128
    [No Abstract]   [Full Text] [Related]  

  • 83. A rapid test for the semi-quantitative estimation of total lipids in serum.
    KLEEBERG J; STEINITZ K
    Nutr Dieta Eur Rev Nutr Diet; 1962; 4():161-8. PubMed ID: 14033323
    [No Abstract]   [Full Text] [Related]  

  • 84. Serum lipids in normal men.
    CARLSON LA
    Acta Med Scand; 1960 Aug; 167():377-97. PubMed ID: 13807770
    [No Abstract]   [Full Text] [Related]  

  • 85. Studies on serum lipids. I. Healthy individuals.
    LUND JC; SIVERTSSEN E; GODAL HC
    Acta Med Scand; 1961 Jun; 169():623-7. PubMed ID: 13764275
    [No Abstract]   [Full Text] [Related]  

  • 86. Editorial: the year in lipids and emerging risk factors.
    Mukherjee D; Mikhailidis DP
    Curr Opin Cardiol; 2022 Jul; 37(4):334. PubMed ID: 35731678
    [No Abstract]   [Full Text] [Related]  

  • 87. Proteinuria and blood pressure as causal components of progression to end-stage renal failure. Northern Italian Cooperative Study Group.
    Locatelli F; Marcelli D; Comelli M; Alberti D; Graziani G; Buccianti G; Redaelli B; Giangrande A
    Nephrol Dial Transplant; 1996 Mar; 11(3):461-7. PubMed ID: 8710157
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Risk factors of renal failure progression two years prior to dialysis.
    Mazouz H; Kacso I; Ghazali A; El Esper N; Moriniere P; Makdassi R; Hardy P; Westeel PF; Achard JM; Pruna A; Fournier A
    Clin Nephrol; 1999 Jun; 51(6):355-66. PubMed ID: 10404696
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Lipid and apolipoprotein patterns during erythropoietin therapy: roles of erythropoietin, route of administration, and diet.
    Allegra V; Martimbianco L; Vasile A
    Nephrol Dial Transplant; 1997 May; 12(5):924-32. PubMed ID: 9175044
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Baseline serum lipids and renal function in chronic kidney disease patients entering the LORD trial.
    Fassett RG; Ball MJ; Robertson IK; Geraghty DP; Coombes JS
    Int J Clin Pharmacol Ther; 2006 Nov; 44(11):580-8. PubMed ID: 17176625
    [TBL] [Abstract][Full Text] [Related]  

  • 91. [Factors in the progression of renal insufficiency during the 2 years preceding the use of dialysis].
    Kacso I; Gherman M; Mazouz H; Ghazali A; el Esper N; Morinière P; Makdassi R; Hardy P; Westeel PF; Achard JM; Pruna A; Fournier A
    Nephrologie; 1999; 20(1):19-28. PubMed ID: 10081033
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Patterns of dietary intake and serum lipids interact with proteinuria as risk factors for progression of chronic renal failure.
    Boaz M; Biro A; Katzir Z; Smetana S
    Ren Fail; 1998 Mar; 20(2):383-90. PubMed ID: 9574466
    [TBL] [Abstract][Full Text] [Related]  

  • 93.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 94.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 95.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 96.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 97.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 98.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 5.